Last updated on March 2019

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

Contact Investigators or Research Sites near you

Start Over

Teva Investigational Site 78122

Parkville, Australia
  Connect »

Teva Investigational Site 78123

Melbourne, Australia
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.